Ken Griffin Mirum Pharmaceuticals, Inc. Transaction History

Citadel Advisors LLC

$509 Billion
Q1 2025

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 14,800 shares of MIRM stock, worth $744,144. This represents 0.0% of its overall portfolio holdings.

Number of Shares

14,800

Previous 2,600 469.23%

Holding current value

$744,144

Previous $107,000 522.43%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$41.32 - $53.16 $2.69 Million - $3.47 Million	-65,188 Reduced 4.31%	1,445,995 $65.1 Million
Q4 2024 Feb 14, 2025	BUY	$37.85 - $46.65 $4.53 Million - $5.59 Million	119,774 Added 8.61%	1,511,183 $62.5 Million
Q3 2024 Nov 14, 2024	SELL	$33.68 - $44.74 $6.54 Million - $8.69 Million	-194,215 Reduced 12.25%	1,391,409 $54.3 Million
Q2 2024 Aug 14, 2024	BUY	$23.57 - $34.85 $4.55 Million - $6.73 Million	193,118 Added 13.87%	1,585,624 $54.2 Million
Q1 2024 May 15, 2024	SELL	$24.92 - $30.02 $1.25 Million - $1.51 Million	-50,306 Reduced 3.49%	1,392,506 $35 Million
Q4 2023 Feb 14, 2024	SELL	$27.14 - $34.93 $7.45 Million - $9.59 Million	-274,445 Reduced 15.98%	1,442,812 $42.6 Million
Q3 2023 Nov 14, 2023	BUY	$24.63 - $32.85 $7.08 Million - $9.44 Million	287,412 Added 20.1%	1,717,257 $54.3 Million
Q2 2023 Aug 14, 2023	BUY	$23.51 - $30.09 $1.42 Million - $1.82 Million	60,500 Added 4.42%	1,429,845 $37 Million
Q1 2023 May 15, 2023	SELL	$19.19 - $24.1 $752,516 - $945,057	-39,214 Reduced 2.78%	1,369,345 $32.9 Million
Q4 2022 Feb 14, 2023	BUY	$17.59 - $23.83 $8.5 Million - $11.5 Million	483,382 Added 52.25%	1,408,559 $27.5 Million
Q3 2022 Nov 14, 2022	BUY	$19.98 - $29.44 $9.9 Million - $14.6 Million	495,330 Added 115.23%	925,177 $19.4 Million
Q2 2022 Aug 15, 2022	BUY	$18.42 - $27.5 $1.78 Million - $2.66 Million	96,819 Added 29.07%	429,847 $8.37 Million
Q1 2022 May 16, 2022	BUY	$15.5 - $23.93 $3.2 Million - $4.94 Million	206,602 Added 163.42%	333,028 $7.33 Million
Q4 2021 Feb 14, 2022	BUY	$13.05 - $19.35 $521,321 - $772,993	39,948 Added 46.19%	126,426 $2.02 Million
Q3 2021 Nov 15, 2021	BUY	$13.95 - $20.18 $1.21 Million - $1.75 Million	86,478 New	86,478 $1.72 Million
Q1 2021 May 17, 2021	SELL	$16.29 - $21.92 $251,468 - $338,379	-15,437 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$15.75 - $25.45 $180,211 - $291,198	-11,442 Reduced 42.57%	15,437 $269,000
Q3 2020 Nov 16, 2020	BUY	$18.4 - $26.59 $252,852 - $365,399	13,742 Added 104.61%	26,879 $518,000
Q2 2020 Aug 14, 2020	BUY	$11.51 - $20.97 $151,206 - $275,482	13,137 New	13,137 $256,000

Others Institutions Holding MIRM

# of Institutions

225

Shares Held

55.4M

Call Options Held

27.4K

Put Options Held

105K

View Full List

About Mirum Pharmaceuticals, Inc.

Ticker MIRM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,751,700
Market Cap $1.85B
Description
Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...

More about MIRM

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account